A Switzerland-based diagnostics company, Biocartis SA, has raised €10 million in a Series A financing round led by Aescap Venture of Amsterdam, the Netherlands. The company has technology for eventual use in in vitro diagnostic settings.
A Switzerland-based diagnostics company, Biocartis SA, has raised €10 million in a Series A financing round led by Aescap Venture of Amsterdam, the Netherlands. The company has technology for eventual use in in vitro diagnostic settings.